VP, Pharmaceutical Sciences
Dr. Wertz leads Nanocopoeia’s research and development efforts aimed at incorporating ElectroSpray technology into novel pharmaceutical drug products. He has more than 18 years of experience in the industry, spanning all stages of development, a wide range of dosage forms, and numerous drug delivery platforms.
Prior to joining Nanocopoeia, Dr. Wertz was Director, Pharmaceutical Development at Upsher-Smith Laboratories, where he was responsible for formulation and process development in support of the company’s ANDA and NDA portfolios. He also worked at Vertex Pharmaceuticals, where he led their line extension formulation development efforts, and at Elan Drug Delivery, where he applied and advanced their proprietary NanoCrystal® technology. Dr. Wertz has M.S. and Ph.D. degrees in Chemical Engineering from Lehigh University and a B.S. degree in Chemical Engineering from the University of Minnesota.